Translations:Nicotine therapeutic benefits/39/en

From Safer nicotine wiki
Jump to navigation Jump to search
  • The secondary outcome measures showed significant nicotine-associated improvements in attention, memory, and psychomotor speed, and improvements were seen in patient/informant ratings of cognitive impairment.
  • Safety and tolerability for transdermal nicotine were excellent.
  • PDF Version
  • Citation: Newhouse P, Kellar K, Aisen P, White H, Wesnes K, Coderre E, Pfaff A, Wilkins H, Howard D, Levin ED. Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial. Neurology. 2012 Jan 10;78(2):91-101. doi: 10.1212/WNL.0b013e31823efcbb. PMID: 22232050; PMCID: PMC3466669.
Retrieved from "https://safernicotine.wiki/mediawiki/index.php?title=Translations:Nicotine_therapeutic_benefits/39/en&oldid=10462"